Bayer, Janssen Score Win In 1st Xarelto Trial

Posted on Posted in Xarelto

(May 4, 2017) – A Louisiana federal jury on Wednesday sided with Janssen and Bayer in the first bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood thinner Xarelto. The jury found in favor of Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in the first of […]

Janssen, Bayer Lose Preemption Bids As Xarelto Trial Nears

Posted on Posted in Xarelto

Law360, New York (April 13, 2017, 8:52 PM EDT) — Days before a first bellwether trial begins in multidistrict litigation over the alleged dangers of blood thinner Xarelto, a Louisiana federal judge on Wednesday refused to drop some claims against Bayer AG and Janssen Pharmaceuticals Inc., saying they can’t necessarily blame U.S. Food and Drug […]

Plaintiffs Stress Role Of Asbestos In Ovarian Cancer Lawsuits Involving Talcum Powder

Posted on Posted in Talcum Powder Cancer Link

Across the country, there are currently over 2,500 lawsuits that aim to prove lifelong use of talcum powder, such as those manufactured by Johnson & Johnson (J&J), are linked to the development of genitourinary cancers, particularly ovarian cancer. In the vast majority of these cases, J&J is the defendant, although Colgate-Palmolive have also faced a […]

Judge Holds Talcum Powder ‘Science Day’ Hearing In Preparation For First California Trial

Posted on Posted in Talcum Powder Cancer Link

Los Angeles—A California state court judge on Tuesday received a day-long crash course on the alleged links between Johnson & Johnson’s talcum powder and ovarian cancer, in a hearing meant to bring her up to speed on the underlying science ahead of a bellwether trial scheduled for July. So-called “science day” hearings are often used […]

More Than 13,000 Xarelto Lawsuits Filed

Posted on Posted in Xarelto

The number of Xarelto lawsuits surpasses over 13,000 pending cases in courts around the nation. The lawsuits target Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The suits claim that the company, along with Bayer AG, failed to provide consumers with adequate warnings about the potentially dangerous side effects of taking the medication. The lawsuits […]

Four XARELTO Trials Scheduled for 2017

Posted on Posted in Xarelto

SAN FRANCISCO, CALIF., UNITED STATES, February 25, 2017 — Plaintiffs in the four lawsuits picked to be tried first in the Xarelto multi-district litigation (MDL) will have to wait a little longer to see their day in court. The four bellwether trials were pushed back another month at the behest of both plaintiffs and defendants. […]